Story thread · 2 reports / 2 sources
This Stock Of The Day Rides Big Pharma Royalties; It's Up 56% In 2026
investors.com · 15d · first report
How the coverage leans
Across 2 sources · syndicated copies counted once
LGND stock has risen more than 56.5% so far in 2026. Ligand doesn't make drugs; it forks over funding in exchange for Big Pharma royalties. The post This Stock Of The Day Rides Big Pharma Royalties; It's Up 56% In 2026 appeared first on Investor's Business Daily .
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.